These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7944499

  • 21. [High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results].
    Conti F, Carpano S, Sergi D, Di Lauro L, Amodio A, Vici P, Abbate MI, Ferranti FR, Viola G, Botti C, Foggi P, Sperduti I, Lopez M.
    Clin Ter; 2007; 158(4):331-41. PubMed ID: 17953285
    [Abstract] [Full Text] [Related]

  • 22. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y, Nishioka A, Inomata T, Hamada N, Terashima M, Yoshida S, Tanaka Y, Ogoshi S, Araki K, Kumon M.
    Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
    [Abstract] [Full Text] [Related]

  • 23. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
    Davidson NE, O'Neill AM, Vukov AM, Osborne CK, Martino S, White DR, Abeloff MD.
    J Clin Oncol; 2005 Sep 01; 23(25):5973-82. PubMed ID: 16087950
    [Abstract] [Full Text] [Related]

  • 24. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
    Pierce LJ, Hutchins LF, Green SR, Lew DL, Gralow JR, Livingston RB, Osborne CK, Albain KS.
    J Clin Oncol; 2005 Jan 01; 23(1):24-9. PubMed ID: 15545669
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O, Izuo M, Enomoto K, Kubo K, Koyama H, Sakai K, Terasawa T, Tominaga T, Nomura Y.
    Gan To Kagaku Ryoho; 1982 May 01; 9(5):866-73. PubMed ID: 7184431
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.
    Cancer J Sci Am; 1998 May 01; 4(2):125-31. PubMed ID: 9554929
    [Abstract] [Full Text] [Related]

  • 30. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
    Schneider J, Lucas R, Sánchez J, Ruibal A, Tejerina A, Martín M.
    Anticancer Res; 2000 May 01; 20(6B):4373-7. PubMed ID: 11205274
    [Abstract] [Full Text] [Related]

  • 31. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A, Azria D, Garaud P, Fourquet A, Serin D, Bosset JF, Miny-Buffet J, Favre A, Le Floch O, Calais G.
    J Clin Oncol; 2007 Feb 01; 25(4):405-10. PubMed ID: 17264336
    [Abstract] [Full Text] [Related]

  • 32. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
    Karlsson YA, Malmström PO, Hatschek T, Fornander TG, Söderberg M, Bengtsson NO, Jansson TE, Sjöberg SM, Bergh JC.
    Cancer; 1998 Sep 01; 83(5):936-47. PubMed ID: 9731898
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report].
    Izumi M, Iino Y, Yokoe T, Inoue T, Yamada T, Kobayashi I, Andoh T, Yokota T, Iijima T, Morishita Y.
    Gan To Kagaku Ryoho; 1994 Feb 01; 21(2):265-8. PubMed ID: 8311500
    [Abstract] [Full Text] [Related]

  • 35. [Effect of CAF'-endocrine therapy on advanced and recurrent breast cancer].
    Une Y, Sato Y, Kagaya H, Miyata S, Matsuoka S, Uchino J, Yakura Y.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 2):2778-81. PubMed ID: 6548892
    [Abstract] [Full Text] [Related]

  • 36. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M.
    Ann Surg; 2002 Sep 01; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [Abstract] [Full Text] [Related]

  • 37. [Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer].
    Mitsuyama S, Kuroda Y, Ohsato K, Nakamura Y, Murakami F, Nishikata F, Ikeda S, Egami T, Mori A, Ohe H.
    Gan To Kagaku Ryoho; 1996 Aug 01; 23(9):1153-60. PubMed ID: 8751803
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Present state of the multidisciplinary treatment of locoregionally advanced breast cancer].
    Izuo M, Iino Y.
    Gan No Rinsho; 1985 Jul 01; 31(9 Suppl):1153-9. PubMed ID: 3840541
    [Abstract] [Full Text] [Related]

  • 40. Eyelid metastasis from breast cancer showing marked response to chemotherapy.
    Zhang GJ, Adachi I, Yin DF, Narabayashi M, Tokue Y, Watanabe T, Kaneko A, Tsuda H, Abe K.
    Jpn J Clin Oncol; 1995 Feb 01; 25(1):10-5. PubMed ID: 7877258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.